Virginia M. Pierce, MD

Clinical Associate Professor of Pathology
University of Michigan Medical School
Ann Arbor, MI, United States

Virginia M. Pierce, MD, FIDSA, is a Clinical Associate Professor of Pathology at the University of Michigan Medical School and a director of the Clinical Microbiology Laboratory at Michigan Medicine. Until May 2022, she was an Associate Director of the Clinical Microbiology Laboratory at Massachusetts General Hospital, where she also served as an attending physician on the Pediatric Infectious Diseases inpatient consultation service and, from 2014-2020, as an Associate Editor of the Case Records of the Massachusetts General Hospital for the New England Journal of Medicine. Dr. Pierce's chief area of expertise is in the development, implementation, and interpretation of antimicrobial susceptibility tests. The principal aim of her scholarship is to improve the accuracy and speed with which clinical microbiology laboratories can characterize the susceptibility profile of pathogens and use this information to advise clinicians about the selection of effective, targeted antimicrobial therapy. Building effective partnerships between clinical microbiology laboratories and antimicrobial stewardship programs is one of her key clinical interests. At the national level, Dr. Pierce has been involved with the Clinical and Laboratory Standards Institute (CLSI) Subcommittee on Antimicrobial Susceptibility Testing since 2016, through which she has contributed to standards and guidelines that are used by clinical laboratories worldwide; she began a term as a voting member of the Subcommittee in 2022. Additionally, Dr. Pierce is the current chairholder of the Document Development Committee revising the CLSI M52 guideline focused on verification of commercial microbial identification and antimicrobial susceptibility testing systems. She is also an editorial board member for the Journal of Clinical Microbiology.

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• 10 - Effective Collaborations Between Stewards and the Microbiology Laboratory

  Thursday, October 20, 2022
  8:00 AM – 9:00 AM US ET

• 29 - A Primer on How the Antibiotic Steward Can Incorporate Novel Diagnostic Assays to Guide Effective Antibiotic Decision Making

  Thursday, October 20, 2022
  8:30 AM – 9:00 AM US ET